These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34650688)
21. Myelin and lymphocyte protein 2 regulates cell proliferation and metastasis through the Notch pathway in prostate adenocarcinoma. Zheng C; Wang J; Zhang J; Hou S; Zheng Y; Wang Q Transl Androl Urol; 2021 May; 10(5):2067-2077. PubMed ID: 34159087 [TBL] [Abstract][Full Text] [Related]
22. LTF Regulates the Immune Microenvironment of Prostate Cancer Through JAK/STAT3 Pathway. Zhao Q; Cheng Y; Xiong Y Front Oncol; 2021; 11():692117. PubMed ID: 34868909 [TBL] [Abstract][Full Text] [Related]
23. Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer. Ge H; Yan Y; Yan M; Guo L; Mao K Med Sci Monit; 2020 Jun; 26():e923208. PubMed ID: 32562536 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape. Li S; Chen J; Chen X; Yu J; Guo Y; Li M; Pu X Front Pharmacol; 2022; 13():997664. PubMed ID: 36110544 [TBL] [Abstract][Full Text] [Related]
25. Screening a novel six critical gene-based system of diagnostic and prognostic biomarkers in prostate adenocarcinoma patients with different clinical variables. Munir H; Ahmad F; Ullah S; Almutairi SM; Asghar S; Siddique T; Abdel-Maksoud MA; Rasheed RA; Elkhamisy FAA; Aufy M; Yaz H Am J Transl Res; 2022; 14(6):3658-3682. PubMed ID: 35836886 [TBL] [Abstract][Full Text] [Related]
26. Utilizing Ubiquitination Patterns to Predict Prostate Cancer Prognosis and Devise a Therapeutic Response. Zhang X; Wang Y; Chang Y; Wang J; Yan S; Xiao Y; Guo T; Lou Y; Ma J; Xu W; Ren S Arch Esp Urol; 2023 May; 76(3):215-231. PubMed ID: 37340527 [TBL] [Abstract][Full Text] [Related]
27. Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy. Yi X; Li J; Zheng X; Xu H; Liao D; Zhang T; Wei Q; Li H; Peng J; Ai J Mol Ther Nucleic Acids; 2023 Sep; 33():376-390. PubMed ID: 37547288 [TBL] [Abstract][Full Text] [Related]
28. Loss of family with sequence similarity 107, member A (FAM107A) induces browning in 3T3-L1 adipocytes. Manigandan S; Mukherjee S; Yun JW Arch Biochem Biophys; 2021 Jun; 704():108885. PubMed ID: 33878327 [TBL] [Abstract][Full Text] [Related]
29. Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma. Zhao HB; Zeng YR; Han ZD; Zhuo YJ; Liang YK; Hon CT; Wan S; Wu S; Dahl D; Zhong WD; Wu CL Cancer Sci; 2021 Oct; 112(10):4365-4376. PubMed ID: 34252262 [TBL] [Abstract][Full Text] [Related]
30. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707 [TBL] [Abstract][Full Text] [Related]
31. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer. Wang R; Xiao Y; Pan M; Chen Z; Yang P J Oncol; 2022; 2022():6768139. PubMed ID: 35909899 [TBL] [Abstract][Full Text] [Related]
32. Multi-Omics Analysis Reveals Clinical Value and Possible Mechanisms of ATAD1 Down-Regulation in Human Prostate Adenocarcinoma. Chen CC; Chu PY; Lin HY Life (Basel); 2022 Oct; 12(11):. PubMed ID: 36362897 [TBL] [Abstract][Full Text] [Related]
33. Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer. Jędroszka D; Orzechowska M; Hamouz R; Górniak K; Bednarek AK PLoS One; 2017; 12(12):e0188842. PubMed ID: 29206234 [TBL] [Abstract][Full Text] [Related]
34. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas. Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846 [TBL] [Abstract][Full Text] [Related]
35. Identification and analysis of survival-associated ceRNA triplets in prostate adenocarcinoma. Li F; Li H; Hou Y Oncol Lett; 2019 Oct; 18(4):4040-4047. PubMed ID: 31579415 [TBL] [Abstract][Full Text] [Related]
36. Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma. Gao Y; Wang G; Chen Y; Zhang M; Gao W; Shang Z; Niu Y Front Genet; 2022; 13():886983. PubMed ID: 35547260 [No Abstract] [Full Text] [Related]
37. Integrative analysis of cancer driver genes in prostate adenocarcinoma. Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096 [TBL] [Abstract][Full Text] [Related]
38. Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors. Kiwerska K; Szaumkessel M; Paczkowska J; Bodnar M; Byzia E; Kowal E; Kostrzewska-Poczekaj M; Janiszewska J; Bednarek K; Jarmuż-Szymczak M; Kalinowicz E; Wierzbicka M; Grenman R; Szyfter K; Marszałek A; Giefing M Sci Rep; 2017 Jul; 7(1):5386. PubMed ID: 28710449 [TBL] [Abstract][Full Text] [Related]
39. Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma. Sui Y; Li S; Zhao Y; Liu Q; Qiao Y; Feng L; Li S Fitoterapia; 2020 Sep; 145():104631. PubMed ID: 32439453 [TBL] [Abstract][Full Text] [Related]
40. Identification of 10 differently expressed lncRNAs as prognostic biomarkers for prostate adenocarcinoma. Wu ZY; Wang SG; Li Q; Zhao QS; Shao MM Math Biosci Eng; 2019 Dec; 17(3):2037-2047. PubMed ID: 32233522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]